Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Affective Disorder | Research article

Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS

Authors: Nidhi Sukul, Junhui Zhao, Douglas S. Fuller, Angelo Karaboyas, Brian Bieber, James A. Sloand, Lalita Subramanian, David W. Johnson, Matthew J. Oliver, Kriang Tungsanga, Tadashi Tomo, Rachael L. Morton, Hal Morgenstern, Bruce M. Robinson, Jeffrey Perl, on behalf of the clinical application of PD therapy working group

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Patient-reported measures are increasingly recognized as important predictors of clinical outcomes in peritoneal dialysis (PD). We sought to understand associations between patient-reported perceptions of the advantages and disadvantages of PD and clinical outcomes.

Methods

In this cohort study, 2760 PD patients in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) completed a questionnaire on their PD experience, between 2014 and 2017. In this questionnaire, PDOPPS patients rated 17 aspects of their PD experience on a 5-category ordinal scale, with responses scored from − 2 (major disadvantage) to + 2 (major advantage). An advantage/disadvantage score (ADS) was computed for each patient by averaging their response scores. The ADS, along with each of these 17 aspects, were used as exposures. Outcomes included mortality, transition to hemodialysis (HD), patient-reported quality of life (QOL), and depression. Cox regression was used to estimate associations between ADS and mortality, transition to HD, and a composite of the two. Logistic regression with generalized estimating equations was used to estimate cross-sectional associations of ADS with QOL and depression.

Results

While 7% of PD patients had an ADS < 0 (negative perception of PD), 59% had an ADS between 0 and < 1 (positive perception), and 34% had an ADS ≥1 (very positive perception). Minimal association was observed between mortality and the ADS. Compared with a very positive perception, patients with a negative perception had a higher transition rate to HD (hazard ratio [HR] = 1.67; 95% confidence interval [CI]: 1.21, 2.30). Among individual items, “space taken up by PD supplies” was commonly rated as a disadvantage and had the strongest association with transition to HD (HR = 1.28; 95% CI 1.07, 1.53). Lower ADS was strongly associated with worse QOL rating and greater depressive symptoms.

Conclusions

Although patients reported a generally favorable perception of PD, patient-reported disadvantages were associated with transition to HD, lower QOL, and depression. Strategies addressing these disadvantages, in particular reducing solution storage space, may improve patient outcomes and the experience of PD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lin E, Cheng XS, Chin KK, Zubair T, Chertow GM, Bendavid E, Bhattacharya J. Home dialysis in the prospective payment system era. J Am Soc Nephrol. 2017;28(10):2993–3004.CrossRef Lin E, Cheng XS, Chin KK, Zubair T, Chertow GM, Bendavid E, Bhattacharya J. Home dialysis in the prospective payment system era. J Am Soc Nephrol. 2017;28(10):2993–3004.CrossRef
2.
go back to reference Nayak Karopadi A, Mason G, Rettore E, Ronco C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol Dial Transplant. 2014;29:885–92.CrossRef Nayak Karopadi A, Mason G, Rettore E, Ronco C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol Dial Transplant. 2014;29:885–92.CrossRef
3.
go back to reference Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant. 2013;28:2553–69.CrossRef Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant. 2013;28:2553–69.CrossRef
4.
go back to reference Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27:3238–52.CrossRef Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27:3238–52.CrossRef
5.
go back to reference Ludlow MJ, George CR, Hawley CM, Mathew TH, Agar JW, Kerr PG, Lauder LA. How Australian nephrologists view home dialysis: results of a national survey: home dialysis survey. Nephrology. 2011;16:446–52.CrossRef Ludlow MJ, George CR, Hawley CM, Mathew TH, Agar JW, Kerr PG, Lauder LA. How Australian nephrologists view home dialysis: results of a national survey: home dialysis survey. Nephrology. 2011;16:446–52.CrossRef
6.
go back to reference Wang V, Maciejewski ML, Coffman CJ, Sanders LL, Lee SD, Hirth R, Messana J. Impacts of geographic distance on peritoneal dialysis utilization: refining models of treatment selection. Health Serv Res. 2017;52:35–55.CrossRef Wang V, Maciejewski ML, Coffman CJ, Sanders LL, Lee SD, Hirth R, Messana J. Impacts of geographic distance on peritoneal dialysis utilization: refining models of treatment selection. Health Serv Res. 2017;52:35–55.CrossRef
7.
go back to reference Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–53.CrossRef Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–53.CrossRef
8.
go back to reference Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–64.PubMed Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–64.PubMed
9.
go back to reference Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT, Group NS. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands cooperative study on the adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis. 2003;41:1293–302.CrossRef Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT, Group NS. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands cooperative study on the adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis. 2003;41:1293–302.CrossRef
10.
go back to reference Lee MJ, Park JT, Park KS, Kwon YE, Oh HJ, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW, Han SH. Prognostic value of residual urine volume, GFR by 24-hour urine collection, and eGFR in patients receiving dialysis. Clin J Am Soc Nephrol. 2017;12:426–34.CrossRef Lee MJ, Park JT, Park KS, Kwon YE, Oh HJ, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW, Han SH. Prognostic value of residual urine volume, GFR by 24-hour urine collection, and eGFR in patients receiving dialysis. Clin J Am Soc Nephrol. 2017;12:426–34.CrossRef
11.
go back to reference Chung SH, Heimbürger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003;18:590–7.CrossRef Chung SH, Heimbürger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003;18:590–7.CrossRef
12.
go back to reference Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–62.PubMed Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–62.PubMed
13.
go back to reference Ludlow MJ, Lauder LA, Mathew TH, Hawley CM, Fortnum D. Australian consumer perspectives on dialysis: first national census: national dialysis census. Nephrology. 2012;17:703–9.CrossRef Ludlow MJ, Lauder LA, Mathew TH, Hawley CM, Fortnum D. Australian consumer perspectives on dialysis: first national census: national dialysis census. Nephrology. 2012;17:703–9.CrossRef
14.
go back to reference Dahlerus C, Quinn M, Messersmith E, Lachance L, Subramanian L, Perry E, Cole J, Zhao J, Lee C, McCall M, Paulson L, Tentori F. Patient perspectives on the choice of dialysis modality: results from the empowering patients on choices for renal replacement therapy (EPOCH-RRT) study. Am J Kidney Dis. 2016;68(6):901–10.CrossRef Dahlerus C, Quinn M, Messersmith E, Lachance L, Subramanian L, Perry E, Cole J, Zhao J, Lee C, McCall M, Paulson L, Tentori F. Patient perspectives on the choice of dialysis modality: results from the empowering patients on choices for renal replacement therapy (EPOCH-RRT) study. Am J Kidney Dis. 2016;68(6):901–10.CrossRef
15.
go back to reference Nakamura-Taira N, Muranaka Y, Miwa M, Kin S, Hirai K. Views of Japanese patients on the advantages and disadvantages of hemodialysis and peritoneal dialysis. Int Urol Nephrol. 2013;45:1145–58.CrossRef Nakamura-Taira N, Muranaka Y, Miwa M, Kin S, Hirai K. Views of Japanese patients on the advantages and disadvantages of hemodialysis and peritoneal dialysis. Int Urol Nephrol. 2013;45:1145–58.CrossRef
16.
go back to reference Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1:1191–6.CrossRef Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1:1191–6.CrossRef
17.
go back to reference Perl J, Davies SJ, Lambie M, Pisoni RL, McCullough K, Johnson DW, Sloand JA, Prichard S, Kawanishi H, Tentori F, Robinson BM. The peritoneal Dialysis outcomes and practice patterns study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit Dial Int. 2016;36:297–307.CrossRef Perl J, Davies SJ, Lambie M, Pisoni RL, McCullough K, Johnson DW, Sloand JA, Prichard S, Kawanishi H, Tentori F, Robinson BM. The peritoneal Dialysis outcomes and practice patterns study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit Dial Int. 2016;36:297–307.CrossRef
18.
go back to reference Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–38.CrossRef Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–38.CrossRef
19.
go back to reference Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10:77–84.CrossRef Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10:77–84.CrossRef
20.
go back to reference Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef
21.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Society, Series B. 1995;57:289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Society, Series B. 1995;57:289–300.
22.
go back to reference IVEware: Imputation and variance estimation software by: Trivellore E. Raghunathan, Peter W. Solenberger, John Van Hoewyk. IVEware: Imputation and variance estimation software by: Trivellore E. Raghunathan, Peter W. Solenberger, John Van Hoewyk.
23.
go back to reference Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987.
24.
go back to reference Kirchgessner J, Perera-Chang M, Klinkner G, Soley I, Marcelli D, Arkossy O, Stopper A, Kimmel PL. Satisfaction with care in peritoneal dialysis patients. Kidney Int. 2006;70:1325–31.CrossRef Kirchgessner J, Perera-Chang M, Klinkner G, Soley I, Marcelli D, Arkossy O, Stopper A, Kimmel PL. Satisfaction with care in peritoneal dialysis patients. Kidney Int. 2006;70:1325–31.CrossRef
25.
go back to reference Lakshmi BS, Kumar A, Reddy HK, Gopal J, Chaitanya V, Chandra VS, Kumar ACV, Reddy HK, Gopal J, Chaitanya V, Chandra VS, Sandeep P, Nagaraju RD, Ram R, Kumar VS. Employment status of patients receiving maintenance dialysis – peritoneal and hemodialysis: a cross-sectional study. Indian J Nephrol. 2017;27:384–8.CrossRef Lakshmi BS, Kumar A, Reddy HK, Gopal J, Chaitanya V, Chandra VS, Kumar ACV, Reddy HK, Gopal J, Chaitanya V, Chandra VS, Sandeep P, Nagaraju RD, Ram R, Kumar VS. Employment status of patients receiving maintenance dialysis – peritoneal and hemodialysis: a cross-sectional study. Indian J Nephrol. 2017;27:384–8.CrossRef
26.
go back to reference Nakayama M, Ishida M, Ogihara M, Hanaoka K, Tamura M, Kanai H, Tonozuka Y, Marshall MR. Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-Centre survey of Japanese patients: Dialysis and socioeconomic status. Nephrology. 2015;20:523–30.CrossRef Nakayama M, Ishida M, Ogihara M, Hanaoka K, Tamura M, Kanai H, Tonozuka Y, Marshall MR. Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-Centre survey of Japanese patients: Dialysis and socioeconomic status. Nephrology. 2015;20:523–30.CrossRef
27.
go back to reference McLaughlin K, Manns B, Mortis G, Hons R, Taub K. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis. 2003;41:380–5.CrossRef McLaughlin K, Manns B, Mortis G, Hons R, Taub K. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis. 2003;41:380–5.CrossRef
29.
go back to reference Jung HY, Jang HM, Kim YW, Cho S, Kim HY, Kim SH, Bang K, Kim HW, Lee SY, Jo SK, Lee J, Choi JY, Cho JH, Park SH, Kim CD, Kim YL, EQLIPS Study Group. Depressive symptoms, patient satisfaction, and quality of life over time in automated and continuous ambulatory peritoneal dialysis patients: a prospective multicenter propensity-matched study. Medicine. 2016;95(21):e3795.CrossRef Jung HY, Jang HM, Kim YW, Cho S, Kim HY, Kim SH, Bang K, Kim HW, Lee SY, Jo SK, Lee J, Choi JY, Cho JH, Park SH, Kim CD, Kim YL, EQLIPS Study Group. Depressive symptoms, patient satisfaction, and quality of life over time in automated and continuous ambulatory peritoneal dialysis patients: a prospective multicenter propensity-matched study. Medicine. 2016;95(21):e3795.CrossRef
30.
go back to reference Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV. Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63:623–35.CrossRef Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV. Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63:623–35.CrossRef
31.
go back to reference Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis. 2003;42:350–4.CrossRef Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis. 2003;42:350–4.CrossRef
32.
go back to reference Guo, A. & Mujais, S. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int. Suppl. 2003;88: S3-12. Guo, A. & Mujais, S. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int. Suppl. 2003;88: S3-12.
33.
go back to reference van der Veer SN, Jager KJ, Visserman E, Beekman RJ, Boeschoten EW, de Keizer NF, Heuveling L, Stronks K, Arah OA. Development and validation of the consumer quality index instrument to measure the experience and priority of chronic dialysis patients. Nephrol Dial Transplant. 2012;27:3284–91.CrossRef van der Veer SN, Jager KJ, Visserman E, Beekman RJ, Boeschoten EW, de Keizer NF, Heuveling L, Stronks K, Arah OA. Development and validation of the consumer quality index instrument to measure the experience and priority of chronic dialysis patients. Nephrol Dial Transplant. 2012;27:3284–91.CrossRef
34.
go back to reference Curtin RB, Johnson HK, Schatell D. The peritoneal dialysis experience: insights from long-term patients. Nephrol Nurs J. 2004;31:615–24.PubMed Curtin RB, Johnson HK, Schatell D. The peritoneal dialysis experience: insights from long-term patients. Nephrol Nurs J. 2004;31:615–24.PubMed
Metadata
Title
Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS
Authors
Nidhi Sukul
Junhui Zhao
Douglas S. Fuller
Angelo Karaboyas
Brian Bieber
James A. Sloand
Lalita Subramanian
David W. Johnson
Matthew J. Oliver
Kriang Tungsanga
Tadashi Tomo
Rachael L. Morton
Hal Morgenstern
Bruce M. Robinson
Jeffrey Perl
on behalf of the clinical application of PD therapy working group
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1304-3

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.